Indications and uses
Cures finger and toe area fungal infections. For effective relief of itching, scaling, cracking, burning, discoloration, soreness, irritation, discomfort and chafing associated with fungal infection.
Cures finger and toe area fungal infections. For effective relief of itching, scaling, cracking, burning, discoloration, soreness, irritation, discomfort and chafing associated with fungal infection.
For nail care, wash and dry affected skin. Apply a thin layer of Pedesil around and under entire nail and cuticle twice daily (morning and night) or as directed by a doctor. If you see improvement within 4 weeks of use, you may continue use until satisfactory results are obtained. For athlete's foot, pay special attention to spaces between toes; wear well fitting, ventilated shoes, and change shoes and socks at le...
Clotrimazole 1%
Antifungal
For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with eyes.
If swallowed, call poison control or seek medical help.
Stop use and ask a doctor if irritation occurs or there is no improvement within 4 weeks.
bentonite clay, distilled water, eucalyptus citriodora oil, jojoba seed oil, silver oxide, tea tree oil, zinc oxide.
Questions? 877-4-AIDANCE
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 309367 | clotrimazole 1 % Topical Cream | PSN | 3 |
| 1250726 | Pedesil 1 % Topical Cream | PSN | 3 |
| 1250726 | clotrimazole 10 MG/ML Topical Cream [Pedesil] | SBD | 3 |
| 309367 | clotrimazole 10 MG/ML Topical Cream | SCD | 3 |
| 309367 | clotrimazole 1 % Topical Cream | SY | 3 |
| 1250726 | Pedesil 1 % Topical Cream | SY | 3 |
| 1250726 | Pedesil 10 MG/ML Topical Cream | SY | 3 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CLOTRIMAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b64d2752-34ef-378a-1f4f-8bff32b0d1ae | Product name | 4 | 20250626 |
| cb7783e0-feaa-7e56-fb3b-d43b6efa77c9 | Product name | 2 | 20250121 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| f5395dd2-4395-d8c6-3477-8c2d4a2f951c | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24909-303-28 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-87fd-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24909-303-28 | Pedesil | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 24909-303-28 | Pedesil | 28 g in 1 BOTTLE | CREAM | 28 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CLOTRIMAZOLE | ACTIVE INGREDIENT | G07GZ97H65 | 3 | |
| CLOTRIMAZOLE | ACTIVE MOIETY | G07GZ97H65 | 3 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 3 | |
| EUCALYPTUS OIL | INACTIVE INGREDIENT | 2R04ONI662 | 3 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 3 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 3 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24909-303 | 24909-303-28 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CLOTRIMAZOLE | G07GZ97H65 | ACTIB |
| BENTONITE | A3N5ZCN45C | IACT |
| EUCALYPTUS OIL | 2R04ONI662 | IACT |
| JOJOBA OIL | 724GKU717M | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| TEA TREE OIL | VIF565UC2G | IACT |
| WATER | 059QF0KO0R | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENTONITE | BENTONITE | A3N5ZCN45C | SUPPOSITORY / VAGINAL | 288.1 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUSPENSION / ORAL | 65 mg/5ml | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER / TOPICAL | 0.67 mg/mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SHAMPOO, SUSPENSION / TOPICAL | 3.25 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET, COATED / ORAL | 1.8 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET / ORAL | 355 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CAPSULE / ORAL | ADJ PH | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SYSTEM / TRANSDERMAL | 9.86 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| EUCALYPTUS OIL | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER, DENTIFRICE / DENTAL | 0.05 mg/mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CREAM / TOPICAL | 4.1 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8370f4bb-1c1a-42f1-b6a5-7b495bb614ed | 5722424d-25ef-47ce-967b-0c8daee65257 | 2012-09-07 | Warnings | 8370f4bb-1c1a-42f1-b6a5-7b495bb614ed 5722424d-25ef-47ce-967b-0c8daee65257 |
Adverse event summaries are temporarily unavailable. Other product information remains available.